FVWVGFYRTSSOLM-UHFFFAOYSA-N
C28H21F7N6O2 — CID 135275043
Data last refreshed: (MolForge compound catalog, from PubChem)
About FVWVGFYRTSSOLM-UHFFFAOYSA-N
FVWVGFYRTSSOLM-UHFFFAOYSA-N (PubChem CID 135275043) has the molecular formula C28H21F7N6O2 and a molecular weight of 606.50 g/mol. Its IUPAC name is 4-[6-fluoro-10-(3,3,4,4,5,5-hexafluoropiperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-3-imidazo[1,2-a]pyridin-3-yl-1,2-dihydropyrrol-5-one.
Molecular Properties
| Compound Name | FVWVGFYRTSSOLM-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 135275043 |
| Molecular Formula | C28H21F7N6O2 |
| Molecular Weight | 606.50 g/mol |
| Exact Mass | 606.16 |
| IUPAC Name | 4-[6-fluoro-10-(3,3,4,4,5,5-hexafluoropiperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-3-imidazo[1,2-a]pyridin-3-yl-1,2-dihydropyrrol-5-one |
| SMILES | O=C1NCC(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CC(F)(F)C(F)(F)C(F)(F)C1)CC2 |
| InChI | InChI=1S/C28H21F7N6O2/c29-16-7-15-11-39(25(43)40-13-26(30,31)28(34,35)27(32,33)14-40)6-5-38-12-19(17(8-16)23(15)38)22-18(9-37-24(22)42)20-10-36-21-3-1-2-4-41(20)21/h1-4,7-8,10,12H,5-6,9,11,13-14H2,(H,37,42) |
| InChIKey | FVWVGFYRTSSOLM-UHFFFAOYSA-N |
| XLogP | 4.63 |
| TPSA | 74.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 606.50 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Perfluorinated_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135275043 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.